Fingolimod in clinical practice: case reports

Abstract

treatment escalation in multiple sclerosis (MS) can be achieved by the use of fingolimod that represents an advancement in treating MS not only due to its mechanism of action, but also because of its dosage form (tablets).

Keywords

• INF-beta-1b
• INF-beta-1a
• glatiramer acetate
• treatment escalation
• fingolimod